Tag - BDTX

Markets

Stifel ups Black Diamond Therapeutics to buy; PT to $10 on Phase 1 data

Stifel upgraded Black Diamond Therapeutics (NASDAQ:BDTX) to “buy” from “hold” and raised its price target to $10 from $2 after the company reported initial dose escalation data demonstrating anti-tumor activity of BDTX...

June 30, 2023

Markets

Stifel starts Black Diamond Therapeutics at hold; PT $10

Stifel initiated coverage of Black Diamond Therapeutics (NASDAQ:BDTX) with a “hold” rating and price target of $10. The stock closed at $9.06 on Sept. 29. Black Diamond is focused on small molecule inhibitors developed...

September 30, 2021

Tag - BDTX

Stifel ups Black Diamond Therapeutics to buy; PT to $10 on Phase 1 data

Stifel starts Black Diamond Therapeutics at hold; PT $10

General

More